Bristol-Myers Squibb
BMY
BMY
1,597 hedge funds and large institutions have $69.4B invested in Bristol-Myers Squibb in 2016 Q4 according to their latest regulatory filings, with 203 funds opening new positions, 561 increasing their positions, 633 reducing their positions, and 102 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
8% more call options, than puts
Call options by funds: $1.49B | Put options by funds: $1.38B
0.15% more ownership
Funds ownership: 70.77% → 70.92% (+0.15%)
11% less repeat investments, than reductions
Existing positions increased: 561 | Existing positions reduced: 633
Holders
1,597
Holding in Top 10
59
Calls
$1.49B
Puts
$1.38B
Top Buyers
| 1 | +$1.31B | |
| 2 | +$896M | |
| 3 | +$691M | |
| 4 |
JP
Jana Partners
New York
|
+$226M |
| 5 |
Jennison Associates
New York
|
+$204M |
Top Sellers
| 1 | -$475M | |
| 2 | -$392M | |
| 3 | -$348M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$275M |
| 5 |
Renaissance Technologies
New York
|
-$242M |